Add BrightSurf on Google Email

Liverpool School of Tropical Medicine


End of community-wide treatment linked to resurgence of parasitic worm infections in Malawi

Researchers found that stopping mass drug administration led to a nearly two-fold increase in intestinal roundworm infections among school-aged children. Community-wide treatment is needed to effectively manage and reduce these infections, highlighting the importance of understanding how disease control programmes interact.

SourceLiverpool School of Tropical Medicine·JournalPLOS Neglected Tropical Diseases·TypeData/statistical analysis·DateApr 14, 2026

Hybrid parasites threaten progress against one of the world’s most widespread neglected diseases

New research reveals hybrid schistosomes are undermining existing disease control strategies by emerging faster than previously recognized. These hybrids can display altered biological traits linked to virulence and transmission potential, complicating diagnosis and treatment.

SourceLiverpool School of Tropical Medicine·JournalPhilosophical Transactions of the Royal Society B Biological Sciences·TypeMeta-analysis·DateJan 8, 2026

Study links gut bacteria to bloodstream infections in newborns within sub-Saharan Africa for the first time

A new study has revealed that the same bacteria causing bloodstream infections in newborns are also found in their gut, making it possible to identify infected infants through stool samples. The research highlights the need for improved surveillance, targeted antibiotic strategies, and interventions to prevent infections.

SourceLiverpool School of Tropical Medicine·JournalCommunications Biology·TypeObservational study·DateDec 10, 2025

Drug kills mosquitoes when they feed through ingestion and surface contact

Nitisinone, a drug used to treat rare genetic disorders, has been shown to be mosquitocidal to several mosquito species, including those that transmit malaria and Zika viruses. The research demonstrates that the drug can kill mosquitoes through ingestion and surface contact, making it a potential tool in combating insecticide resistance.

SourceLiverpool School of Tropical Medicine·JournalParasites & Vectors·DateAug 7, 2025

Widely used malaria treatment to prevent malaria in pregnant women

The study found that the widely used antimalarial sulphadoxine-pyrimethamine (SP) is no longer effective in preventing malaria in areas with high levels of resistance. In areas where more than 37% of parasites carry six mutations, the effectiveness of SP appears to be fully compromised. The researchers are calling for further investiga...

SourceLiverpool School of Tropical Medicine·JournalThe Lancet Infectious Diseases·DateMar 25, 2019

Being HIV positive and staying on antiretroviral therapy in Africa: A systematic review

The systematic review identified nine themes impacting on adherence and treatment seeking, including external issues such as poverty and stigma. Long-term engagement requires adaptation and incorporation of ART into daily life, facilitated by factors like self-efficacy and emotional support. The review aims to inform service delivery a...

Parasites from patients with cerebral malaria stick preferentially in their brains

Researchers found that infected red blood cells from cerebral malaria patients bind more strongly to brain-derived cells than those from uncomplicated malaria patients. This suggests that specific PfEMP1 proteins on the infected red blood cells allow for efficient binding to brain vessels, a key feature of cerebral malaria.

SourceLiverpool School of Tropical Medicine·JournalEMBO Molecular Medicine·DateJan 11, 2019

New anti-Wolbachia drug with potential to treat onchocerciasis and lymphatic filariasis

Researchers have developed a novel fully synthetic and rationally designed anti-Wolbachia drug, AWZ1066S, which could potentially treat onchocerciasis and lymphatic filariasis. The compound has shown high specificity and potency against Wolbachia, with the potential to shorten treatment times from weeks to days.

SourceLiverpool School of Tropical Medicine·JournalProceedings of the National Academy of Sciences·DateJan 8, 2019

Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria

Researchers found pyronaridine-artesunate to be as effective as currently used artemisinin-based combination therapies for treating uncomplicated P. falciparum malaria. Mild liver injuries were observed in some patients but no severe damage was reported. The treatment holds promise for areas with rising artemisinin resistance.

SourceLiverpool School of Tropical Medicine·JournalCochrane Database of Systematic Reviews·DateJan 8, 2019